UnitedHealth Group Incorporated (NYSE:UNH) Shares Sold by Kesler Norman & Wride LLC

Kesler Norman & Wride LLC reduced its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 12.6% in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,769 shares of the healthcare conglomerate’s stock after selling 2,710 shares during the quarter. UnitedHealth Group accounts for about 2.2% of Kesler Norman & Wride LLC’s holdings, making the stock its 5th biggest position. Kesler Norman & Wride LLC’s holdings in UnitedHealth Group were worth $10,975,000 as of its most recent SEC filing.

Other hedge funds have also recently made changes to their positions in the company. Aprio Wealth Management LLC raised its position in shares of UnitedHealth Group by 18.4% in the third quarter. Aprio Wealth Management LLC now owns 1,154 shares of the healthcare conglomerate’s stock valued at $675,000 after purchasing an additional 179 shares during the period. Ignite Planners LLC boosted its stake in shares of UnitedHealth Group by 11.2% in the 3rd quarter. Ignite Planners LLC now owns 1,353 shares of the healthcare conglomerate’s stock valued at $791,000 after purchasing an additional 136 shares in the last quarter. Versant Capital Management Inc boosted its stake in shares of UnitedHealth Group by 17.8% in the 3rd quarter. Versant Capital Management Inc now owns 1,011 shares of the healthcare conglomerate’s stock valued at $591,000 after purchasing an additional 153 shares in the last quarter. IMZ Advisory Inc raised its holdings in UnitedHealth Group by 9.5% during the 3rd quarter. IMZ Advisory Inc now owns 659 shares of the healthcare conglomerate’s stock valued at $390,000 after buying an additional 57 shares during the last quarter. Finally, Salvus Wealth Management LLC raised its holdings in UnitedHealth Group by 5.9% during the 3rd quarter. Salvus Wealth Management LLC now owns 1,069 shares of the healthcare conglomerate’s stock valued at $625,000 after buying an additional 60 shares during the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at UnitedHealth Group

In other news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the transaction, the executive vice president now owns 7,785 shares of the company’s stock, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. In related news, EVP Erin Mcsweeney sold 1,500 shares of the business’s stock in a transaction on Thursday, July 18th. The shares were sold at an average price of $579.03, for a total value of $868,545.00. Following the sale, the executive vice president now owns 7,785 shares in the company, valued at approximately $4,507,748.55. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CAO Thomas E. Roos sold 2,851 shares of the business’s stock in a transaction on Wednesday, July 17th. The shares were sold at an average price of $569.88, for a total transaction of $1,624,727.88. Following the transaction, the chief accounting officer now owns 29,501 shares in the company, valued at $16,812,029.88. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders own 0.33% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on UNH shares. Wells Fargo & Company upped their price target on shares of UnitedHealth Group from $525.00 to $630.00 and gave the company an “overweight” rating in a report on Wednesday, July 17th. TD Cowen raised their target price on shares of UnitedHealth Group from $546.00 to $601.00 and gave the stock a “buy” rating in a research report on Wednesday, July 17th. StockNews.com cut shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Wednesday, September 25th. Robert W. Baird raised their target price on shares of UnitedHealth Group from $597.00 to $640.00 and gave the stock an “outperform” rating in a research report on Wednesday, July 17th. Finally, Morgan Stanley raised their target price on shares of UnitedHealth Group from $595.00 to $615.00 and gave the stock an “overweight” rating in a research report on Wednesday, July 17th. Two research analysts have rated the stock with a hold rating, eighteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and a consensus price target of $614.17.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $583.58 on Tuesday. The firm has a 50 day moving average of $582.24 and a 200 day moving average of $527.84. The company has a current ratio of 0.88, a quick ratio of 0.88 and a debt-to-equity ratio of 0.67. The firm has a market capitalization of $537.12 billion, a price-to-earnings ratio of 35.67, a price-to-earnings-growth ratio of 1.65 and a beta of 0.58. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $607.94.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, July 16th. The healthcare conglomerate reported $6.80 earnings per share for the quarter, beating the consensus estimate of $6.66 by $0.14. UnitedHealth Group had a net margin of 3.66% and a return on equity of 26.55%. The business had revenue of $98.86 billion for the quarter, compared to the consensus estimate of $98.73 billion. During the same quarter in the previous year, the firm earned $6.14 earnings per share. The company’s revenue for the quarter was up 6.4% on a year-over-year basis. On average, research analysts anticipate that UnitedHealth Group Incorporated will post 27.69 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 24th. Stockholders of record on Monday, September 16th were issued a $2.10 dividend. This represents a $8.40 annualized dividend and a dividend yield of 1.44%. The ex-dividend date of this dividend was Monday, September 16th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 51.34%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.